510(k) device
Modulith SLX-F2
Karl Storz Endoscopy America · Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS, Class II) · First FDA decision Mar 30, 2021, newest Mar 30, 2021Kidney stones
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Modulith SLX-F2"
MAUDE reports
54
Brand "Modulith SLX-F2", since 2015
PubMed studies
26
Mentioning "Modulith SLX-F2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Modulith SLX-F2
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Modulith SLX-F2510(k)
K201001 · Decided Mar 30, 2021 · 348 days after receipt
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Modulith SLX-F2", any status and sponsor, newest update first.
- PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney StonesPivotal-lookingRecruiting
Storz Medical AGNot on our public-company list
NCT07272720 · 126 participants (planned) · Start Dec 11, 2025 · Primary completion Dec 2027
Device: ESWL with kidney stone tracking (StorM-Track); Standard ESWL without stone tracking (StorM-Track disabled) · For: Kidney Stones; Urolithiasis
Sites: Stockholm, Sweden
Odense University HospitalAcademic, hospital or other
NCT02515461 · 30 participants (planned) · Start Jul 2015 · Primary completion Jan 2022
Device: Low energy shockwave therapy · For: Diabetic Nephropathies
Sites: Odense, Denmark
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Modulith SLX-F2", and for the whole product code for context.
This brand
54 reports: 1 malfunction, 50 injury, 2 death
Whole product code LNS
605 reports: 95 malfunction, 498 injury, 11 death
Newest reports for this brand
- Modulith SLX-F2Injury
9613347-2026-00006 · Received Oct 19, 2026 · Event dated Oct 12, 2026
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hematoma
- Modulith SLX-F2Injury
9613347-2026-00005 · Received Sep 30, 2026 · Event dated Sep 5, 2026
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hematoma
- Modulith SLX F2Injury
9613347-2026-00003 · Received Aug 26, 2026 · Event dated Jul 27, 2026
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hematoma; Hemorrhage/Blood Loss/Bleeding
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Modulith SLX-F2"[tiab]. The summary above synthesizes these.
- A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.
Zehnder P, Roth B, Birkhäuser F, et al. · Eur Urol · 2011Comparative Study, Randomized Controlled Trial
- Factors determining stone-free rate in shock wave lithotripsy using standard focus of Storz Modulith SLX-F2 lithotripter.
Elkoushy MA, Hassan JA, Morehouse DD, et al. · Urology · 2011Research Support, Non-U.S. Gov't
- Matched pair analysis of wide versus narrow focus during shockwave lithotripsy for urolithiasis.
Sharp AJ, Lovegrove CE, Sreekumar R, et al. · Urolithiasis · 2024Comparative Study
- [A single center experience with a lithotripsy machine "Modulith SLX-F2" : evaluation of dual focus system and clinical results].
Suzuki K, Yamashita Y, Yoshida M, et al. · Hinyokika Kiyo · 2010Evaluation Study
- How efficient is extracorporeal shockwave lithotripsy with modern lithotripters for removal of ureteral stones?
Tiselius HG · J Endourol · 2008
- Risk factors for perinephric hematoma formation after shockwave lithotripsy: a matched case-control analysis.
Razvi H, Fuller A, Nott L, et al. · J Endourol · 2012Clinical Trial
- Effect of Focal Zone Size on Treatment Outcomes and Renal Injury Following Extracorporeal Shockwave Lithotripsy of Renal Calculi: A Prospective Randomized Study.
Ng CF, Yee CH, Teoh JYC, et al. · J Endourol · 2024Randomized Controlled Trial
- Relationship Between Patient Position and Pain Severity During Shock Wave Lithotripsy for Renal Stones With the MODULITH SLX-F2 Lithotripter: A Matched Case-Control Study.
Kang JH, Lee SW, Moon SH, et al. · Korean J Urol · 2013
- In Vitro Assessment of Three Clinical Lithotripters Employing Different Shock Wave Generators.
Faragher SR, Cleveland RO, Kumar S, et al. · J Endourol · 2016Comparative Study
- Re: Pascal Zehnder, Beat Roth, Frédéric Birkhäuser, et al. A prospective randomised trial comparing the modified HM3 with the MODULITH(®) SLX-F2 lithotripter. Eur Urol 2011;59:637-44.
Rassweiler J · Eur Urol · 2011Letter, Comment
- Audiovisual distraction reduces pain perception during shockwave lithotripsy.
Marsdin E, Noble JG, Reynard JM, et al. · J Endourol · 2012Randomized Controlled Trial
- Dual-frequency setting for urinary stone fragmentation during shock wave lithotripsy: an in vitro study.
Han CS, Vetter JM, Endicott R, et al. · Urolithiasis · 2020
Other devices of this type
Also filed under product code LNS.
- Delta III LithotripterDornier Medtech America, Inc. · 510(k) 2020
- Break WaveSonomotion, Inc. · 510(k) 2026
- Tripter X-1 CompactDirex Systems Corp. · 510(k) 2004
- Extracorporeal Shock Wave Lithotripter (U200)Shenzhen Wikkon Precision Technologies Co., Ltd. · 510(k) 2025
- Delta III ProDornier Medtech America, Inc. · 510(k) 2023
- LM-9300 Plus LithotripterLite-Med, Inc. · 510(k) 2023
- Gemini XXP-HPDornier Medtech America · 510(k) 2015
- LM-9300 ELMA LithotripterLite-Med, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.